Clinical Trial Update: Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for dual-target CAR-T cells in B-cell acute lymphoblastic leukemia (B-ALL) with relapse/refractory disease, status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Dual-target CAR-T cells (null)

Snippet

Sponsor: Shenzhen University General Hospital | Conditions: Dual-target CAR-T Cells, B ALL | Phase 1, Phase 2 | Status: UNKNOWN